Coumou Jeroen, de Vries Peter J
Tergooi Ziekenhuis, afd. Interne Geneeskunde, Hilversum.
Contact: Jeroen Coumou (
Ned Tijdschr Geneeskd. 2020 Mar 11;164:D4936.
Since the outbreak of COVID-19, chloroquine has been mentioned as a possible treatment. In vitro studies have shown anti-viral activity of chloroquine against SARS-CoV-2. Recently, the Dutch National Institute for Public Health and the Environment published treatment options for antiviral treatment for COVID-19 where chloroquine was suggested as first choice for off-label treatment, beside remdesivir en lopinavir/ritonavir. In this commentary, we provide a background and history of chloroquine, the evidence for antiviral efficacy of chloroquine and the arguments for off-label use of chloroquine in COVID-19.
自新冠疫情爆发以来,氯喹一直被提及可能作为一种治疗手段。体外研究已显示氯喹对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)具有抗病毒活性。最近,荷兰国家公共卫生与环境研究所公布了新冠病毒的抗病毒治疗方案,其中氯喹被建议作为标签外治疗的首选,与瑞德西韦及洛匹那韦/利托那韦并列。在这篇评论中,我们提供了氯喹的背景和历史、氯喹抗病毒疗效的证据以及在新冠疫情中氯喹标签外使用的依据。